CVE-2008-1277

Public Exploit

Description

The IMAP service (MEIMAPS.exe) in MailEnable Professional Edition and Enterprise Edition 3.13 and earlier allows remote attackers to cause a denial of service (crash) via (1) SEARCH and (2) APPEND commands without required arguments, which triggers a NULL pointer dereference.

Category

9.0
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 6.50% Top 10%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/29277 third party advisory vendor advisory
http://aluigi.altervista.org/adv/maildisable-adv.txt
http://www.vupen.com/english/advisories/2008/0799/references vdb entry
http://securityreason.com/securityalert/3724 third party advisory
http://www.securityfocus.com/archive/1/489270/100/0/threaded mailing list
http://www.securitytracker.com/id?1019565 vdb entry
http://www.securityfocus.com/bid/28145 vdb entry exploit
https://exchange.xforce.ibmcloud.com/vulnerabilities/41059 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-1277?
CVE-2008-1277 has been scored as a critical severity vulnerability.
How to fix CVE-2008-1277?
To fix CVE-2008-1277, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-1277 being actively exploited in the wild?
It is possible that CVE-2008-1277 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~6% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.